Literature DB >> 15087823

Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia.

Martin Matejovic1, Ales Krouzecky, Vendula Martinkova, Richard Rokyta, Hana Kralova, Vladislav Treska, Peter Radermacher, Ivan Novak.   

Abstract

We have recently demonstrated that selective inducible nitric oxide (NO) synthase (iNOS) inhibition with 1400W attenuated the hemodynamic and metabolic alterations affiliated with hyperdynamic porcine endotoxemia. In contrast to endotoxemia, limited evidence is available to document a relationship between NO and organ dysfunction in large animal bacteremic models. Therefore, using the same experimental setup, we investigated the role of selective iNOS blockade in porcine bacteremia induced and maintained for 24 h with a continuous infusion of live Pseudomonas aeruginosa. After 12 h of sepsis, animals received either vehicle (Control, n = 8) or continuous infusion of selective iNOS inhibitor, L-N6-(1-iminoethyl)-lysine (L-NIL; n = 8). Measurements were performed before, and 12, 18, and 24 h after P. aeruginosa infusion. L-NIL inhibited sepsis-induced increase in plasma nitrate/nitrite concentrations and prevented hypotension without affecting cardiac output. Despite comparable hepatosplanchnic macrocirculation, L-NIL blunted the progressive deterioration in ileal mucosal microcirculation and prevented mucosal acidosis. L-NIL largely attenuated mesenteric and hepatic venous acidosis, significantly improved P. aeruginosa-induced impairment of hepatosplanchnic redox state, and mitigated the decline in liver lactate clearance. Furthermore, the administration of L-NIL reduced the hepatocellular injury and prevented the development of renal dysfunction. Finally, treatment with L-NIL significantly attenuated the formation of 8-isoprostane concentrations, a direct marker of lipid peroxidation. Thus, selective iNOS inhibition with L-NIL prevented live bacteria from causing key features of metabolic derangements in porcine hyperdynamic sepsis. Underlying mechanisms probably include reduced oxidative stress with improved microcirculatory perfusion and restoration of cellular respiration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087823     DOI: 10.1097/00024382-200405000-00010

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  25 in total

1.  Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Authors:  Martin Matejovic; Can Ince; Lakhmir S Chawla; Roland Blantz; Bruce A Molitoris; Mitchell H Rosner; Mark D Okusa; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-28       Impact factor: 10.121

Review 2.  Mitochondrial function and dysfunction in sepsis.

Authors:  Martina Wendel; Axel R Heller
Journal:  Wien Med Wochenschr       Date:  2010-03

3.  Inducible nitric oxide synthase inhibition improves intestinal microcirculatory oxygenation and CO2 balance during endotoxemia in pigs.

Authors:  Martin Siegemund; Jasper van Bommel; Lothar A Schwarte; Wolfgang Studer; Thierry Girard; Stephan Marsch; Peter Radermacher; Can Ince
Journal:  Intensive Care Med       Date:  2005-06-15       Impact factor: 17.440

4.  High versus standard-volume haemofiltration in hyperdynamic porcine peritonitis: effects beyond haemodynamics?

Authors:  Roman Sykora; Jiri Chvojka; Ales Krouzecky; Jaroslav Radej; Thomas Karvunidis; Veronika Varnerova; Ivan Novak; Martin Matejovic
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

Review 5.  Bench-to-bedside review: nitric oxide in critical illness--update 2008.

Authors:  Steven M Hollenberg; Ismail Cinel
Journal:  Crit Care       Date:  2009-07-16       Impact factor: 9.097

6.  Right man, right time, right place?--on the time course of the mediator orchestra in septic shock.

Authors:  Balázs Hauser; Peter Radermacher
Journal:  Crit Care       Date:  2010-08-23       Impact factor: 9.097

7.  The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock.

Authors:  Gerd Albuszies; Josef Vogt; Ulrich Wachter; Christoph Thiemermann; Xavier M Leverve; Sandra Weber; Michael Georgieff; Peter Radermacher; Eberhard Barth
Journal:  Intensive Care Med       Date:  2007-04-26       Impact factor: 17.440

Review 8.  [Pathomechanisms of organ failure. Mitochondrial dysfunction in sepsis].

Authors:  M Wendel; A R Heller; T Koch
Journal:  Anaesthesist       Date:  2009-04       Impact factor: 1.041

Review 9.  Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.

Authors:  Suzanne Heemskerk; Rosalinde Masereeuw; Frans G M Russel; Peter Pickkers
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

10.  Angiotensin II in experimental hyperdynamic sepsis.

Authors:  Li Wan; Christoph Langenberg; Rinaldo Bellomo; Clive N May
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.